Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency

PURPOSE: Patients with secondary adrenal insufficiency (SAI) have an increased morbidity and an impaired health-related quality of life (HRQoL), which seems to primarily depend on the sub-optimal replacement of hypoadrenalism with standard glucocorticoid (GC) therapy, and on the inadequate correctio...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasco, V., Giannelli, J., Campioni, L., Arvat, E., Ghigo, E., Grottoli, S., Maccario, M., Giordano, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938071/
https://www.ncbi.nlm.nih.gov/pubmed/36251244
http://dx.doi.org/10.1007/s40618-022-01940-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938071/
https://www.ncbi.nlm.nih.gov/pubmed/36251244
http://dx.doi.org/10.1007/s40618-022-01940-1

Ejemplares similares